Dr. Jorge Gallardo Ballart announces his intention to retire from his positions of President of the Board of Directors and Board member of Almirall

Rhea-AI Summary

Dr. Jorge Gallardo Ballart will retire as Chairman and Board member of Almirall effective after the General Shareholders Meeting on May 6, 2022. Mr. Carlos Gallardo Piqué, currently Vice-President, will succeed him. Carlos brings extensive healthcare experience, having served in significant roles at Almirall and as a venture capitalist in digital health. Carlos expressed excitement about leading Almirall towards becoming a Medical Dermatology leader and improving patient care. The Board thanked Jorge for his 50-year leadership, highlighting his contributions to the company.

Positive

• Carlos Gallardo Piqué is appointed as new Chairman, bringing extensive industry experience.
• The transition is seen as well-planned, indicating stable leadership moving forward.
• Carlos has a strong background in both pharmaceutical and digital health sectors.

Negative

• None.

BARCELONA, Feb. 21, 2022 /PRNewswire/ -- Almirall, S.A. (ALM) in accordance with the Stock Exchange Act, communicates the following:

Dr. Jorge Gallardo Ballart has announced in the Board of Directors' session on Friday 18^th February, his intention to retire from his positions of Chairman of the Board of Directors and Board member with effect as of the end of the General Shareholders Meeting of Almirall, S.A. that will take place next 6 May 2022. In light of  this decision, which has been carefully planned, the Board of Directors has appointed Mr. Carlos Gallardo Piqué, current Vice-President of the Board, as President of the Board of Directors of Almirall with effect from the end of the aforementioned General Shareholders Meeting. Mr. Carlos Gallardo has accepted his nomination.

Carlos has broad international healthcare experience. He started his pharmaceutical career in Pfizer prior to joining Almirall where he held positions of increasing seniority over nearly 10 years. Since leaving Almirall as General Manager of the UK and Ireland in 2013, Carlos has served as a member of Almirall's Board of Directors. In addition, he has established a successful career as a venture capitalist investing in digital health. He is the founder and CEO of CG Health Ventures where he invests in and builds digital health companies that match technology and talent to solve for challenges in healthcare. He serves on a number of boards of promising early stage digital health and health technology companies. Carlos holds an MS in industrial Engineering from the Universitat Politècnica de Catalunya and an MBA from Stanford University's Graduate School of Business.

Mr. Carlos Gallardo said: "I am very pleased  that I will assume this new role as Chairman of Almirall and I´ll keep working to bring the company to the next level as a Medical Dermatology leader. Almirall is poised for growth and it is exciting to be part of this amazing journey. I am looking forward to working with the management team, the employees and Board of Directors in bringing innovative products in Medical Dermatology to improve the quality of patients' lives and grow the company going forward."

The Board of Directors wishes to thank Dr. Jorge Gallardo for his immense contribution to Almirall. For over 50 years he has committed himself to creating one of Spain's most successful R&D based companies and has led the company with great distinction.

Dr. Jorge Gallardo stated: "It has been a great privilege and pleasure to lead Almirall. We have had major successes and faced many challenges. I believe the company now has an exciting future ahead of it and that we have in place the management team and Board of Directors who can deliver this. I wish Carlos much success in his new role and in this new chapter of the company."

View original content:https://www.prnewswire.com/news-releases/dr-jorge-gallardo-ballart-announces-his-intention-to-retire-from-his-positions-of-president-of-the-board-of-directors-and-board-member-of-almirall-301486317.html

SOURCE Almirall, S.A.

FAQ

What is the reason for Dr. Jorge Gallardo's retirement from Almirall?

Dr. Jorge Gallardo announced his retirement to facilitate a planned transition in leadership, effective after the General Shareholders Meeting on May 6, 2022.

Who will replace Dr. Jorge Gallardo as Chairman of Almirall?

Mr. Carlos Gallardo Piqué, currently the Vice-President of the Board, has been appointed as the new Chairman of Almirall.

What experience does Carlos Gallardo Piqué bring to his new role at Almirall?

Carlos Gallardo Piqué has extensive experience in the pharmaceutical industry, having held key positions at Almirall and previously at Pfizer, along with a successful venture capital career in digital health.

What are Carlos Gallardo's goals as the new Chairman of Almirall?

Carlos aims to lead Almirall towards becoming a Medical Dermatology leader and to innovate products that improve patient lives.